- Keefe Bruyette upgraded Intercontinental Exchange (NYSE: ICE) to Outperform from Market Perform on expectations that derivatives trading will increase in the coming quarters.
- NutriSystem (NASDAQ: NTRI) was upgraded to Buy from Neutral by Janney Montgomery, which believes that the company's earnings have hit bottom, while the company could report better-than-expected Q1 results.
- Harley-Davidson (NYSE: HOG) was upgraded to Outperform from Sector Perform at RBC Capital. The firm thinks the company is an early-cycle story that has significant upside potential.
- UBS upgraded Walgreen (NYSE: WAG) to Buy from Neutral citing cost cutting efforts and slowing store growth.
- Google (NASDAQ: GOOG) was upgraded to Buy from Hold at Benchmark Co.
- Safeway (NYSE: SWY) was upgraded to Buy from Hold by BB&T.
- Needham upgraded Targacept (NASDAQ: TRGT) to Buy from Hold.
- Sierra Wireless (NASDAQ: SWIR) was raised to Buy from Hold at Jesup & Lamont.
Analyst upgrades, downgrades and initiations: GOOG, HOG, NOK, SWY, WAG, WSM ...
Continue reading Analyst upgrades, downgrades and initiations: GOOG, HOG, NOK, SWY, WAG, WSM ...
Walgreen (WAG): More healthy returns
"Walgreen (NYSE: WAG) reported fourth quarter profits that topped Wall Street's expectations," says Geoffrey Seiler.
In his BullMarket,com advisory, he forecasts, "We expect to see continued operational improvements in the months ahead." Here, the advisor reiterates his buy rating and boosts his price target for the stock.
The advisor observes,, "The company reported a net profit of $436 million, or 44 cents per share, for the quarter ended August 31st, a -1.5% decrease the same quarter a year ago. Results topped the Wall Street consensus by 5 cents share and edged the full-year EPS estimate by 3 cents.
Earnings highlights: Nike, Walgreen, Jabil Circuit, Gannett, Darden ...
Here are some highlights from last week's earnings coverage from BloggingStocks:
- Accenture Ltd. (NYSE: ACN) lower Q4 earnings met analysts' expectations but the Q1 outlook was weak.
- Cal-Maine Foods Inc. (NASDAQ: CALM) posted a Q1 net loss and said it will skip its dividend this quarter.
- Cephalon Inc. (NASDAQ: CEPH) earnings prospects for 2010 resulted in an analyst's downgrade.
- Darden Restaurants Inc. (NYSE: DRI) Q1 earnings beat by a penny but revenue fell short of estimates.
- Gannett Inc. (NYSE: GCI) shares rose after it forecast Q3 earnings above Wall Street estimates.
Continue reading Earnings highlights: Nike, Walgreen, Jabil Circuit, Gannett, Darden ...
Walgreens (WAG) September sales grow by 10%
Walgreen (NYSE: WAG - option chain) shares are rising today after the company announced its September sales rose 10.3% higher than the same period last year. Same-store-sales were up 5.3%, buoyed by pharmacy increases of 7%, while other merchandise saw just a 2% gain. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on WAG.WAG opened this morning at $38.35. So far today the stock has hit a low of $37.92 and a new 52-week high of $38.75. As of 11:45, WAG is trading at $38.21 up 2 cents (0.05%). The chart for WAG looks neutral and S&P gives WAG a neutral 3 STARS (out of 5) hold ranking.
Continue reading Walgreens (WAG) September sales grow by 10%
Some big names set new 52-week highs Tuesday: WAG, ACS, WYE ...
All three of the major indexes finished Tuesday in the red, but there were several big names that moved up to new 52-week highs in Tuesday's trading.Walgreen Co. (NYSE: WAG): The drugstore giant had a really good day on Wall Street after posting better than expected earnings in the morning before the market opened. The company posted earnings of 44 cents per share versus analyst estimates of 39 cents. The stock set a new 52-week high of $38.44 and closed the day up 9.2% at $37.35.
Continue reading Some big names set new 52-week highs Tuesday: WAG, ACS, WYE ...
Walgreen (WAG) soars on earnings report
Shares of drugstore giant Walgreen Co. (NYSE: WAG) have been soaring today after topping analyst estimates for its fiscal fourth quarter.Going into today's earnings report, analysts had been expecting the company to show earnings of 39 cents per share, but the company surprised to the upside by showing earnings for the quarter of 44 cents per share. In reaction to the better than expected earnings, shares of Walgreen have traded up 9% this morning to $37.28, up $3.09.
Walgreen to miss earnings expectations again in Q4?
Walgreen Co. NYSE: WAG), the the nation's largest drugstore chain, is scheduled to discuss its fiscal fourth quarter 2009 results Tuesday in a conference call at 7:30 AM ET. You can catch the live webcast of the call on the company's website.
The Deerfield, Ill.-based pharmacy giant appointed a new treasurer and also increased its quarterly dividend during the three months that ended in August. Analysts surveyed by Thomson Reuters expect Walgreen to report that net income for that period fell 13.3% from a year ago to 39 cents per share. However, revenue for the quarter is expected to be 7.4% higher to $15.7 billion.
Continue reading Walgreen to miss earnings expectations again in Q4?
Efforts to cope with swine flu likely to increase traffic at CVS, Walgreen
I'm reiterating Buy ratings for giant drug store chains CVS-Caremark (NYSE: CVS) and Walgreen (NYSE: WAG) on likely increased store traffic, due to the H1N1 flu. So far, the nation is doing fairly well at ensuring that there will be enough swine flu vaccine for key populations --those who could quickly spread the virus like teachers, health care workers, emergency personnel etc., as well as other risk groups -- pregnant women, people caring for infants, people aged 25-64 who are at high risk due to compromised immune systems.
Continue reading Efforts to cope with swine flu likely to increase traffic at CVS, Walgreen
Walgreen (WAG): An Obama boost
"Healthcare-related stocks have been trading up and down based on the latest rumor of how the Obama medical plan might be implemented," observes analyst Glenn Rogers.
The contributing editor to Gordon Pape's Internet Wealth Builder asks, "How can we benefit from Obama-Care?" Here, the advisor looks at Walgreen (NYSE: WAG), the largest drugstore chain in the U.S."
"A recent article in Barron's suggested that Walgreens, Caremark CVS, and Target could benefit from whatever new healthcare system emerges from Congress. (Note, Caremark CVS was covered in a previous post today.)
Walgreen: Cost containment should send shares north
I'm Reiterating my Buy rating for Walgreen Company (NYSE: WAG), first recommended on February 17, 2009 at a price of $25.46. Walgreen's ambitious cost-containment effort appears to be on-track, but it may be several quarters before earnings per share experience the full benefit of the company's restructuring. Back-store (mostly prescriptions) revenue growth has resumed, which is gratifying; WAG always was a star performer concerning front-store revenue among the drug chains.
Continue reading Walgreen: Cost containment should send shares north
Closing Bell: When it feels like a coin toss (AA, WAG, COST, GS, C, GE)
Today was treated as a "labor data anomaly" as the jobless claims finally broke under 600,000 for the week. The problem was that it was a holiday week and the continuing claims grew much larger. Warren Buffet gunning for a second stimulus package probably didn't help matters, nor did lower commodity prices based on economic fears. Here are the unofficial closing bell levels:Dow 8,183.17 +4.76 (0.06%)
S&P 500 882.68 +3.12 (0.35%)
Nasdaq 1,752.55 +5.38 (0.31%)
Top Analyst Upgrades
Top Analyst Downgrades
Continue reading Closing Bell: When it feels like a coin toss (AA, WAG, COST, GS, C, GE)
Earnings highlights: Nike, Oracle, Kroger, Walgreen, Monsanto, KB Home ...
Here are some highlights from this past week's earnings coverage from BloggingStocks:
- Accenture Ltd. (NYSE: ACN) beat earnings expectations but revenue was hurt by currency effects.
- Bed Bath & Beyond Inc. (NASDAQ: BBBY) strong Q1 results beat estimates but same-store sales fell.
- CKE Restaurants Inc. (NYSE: CKR) lower Q1 earnings and strong sales both topped expectations.
- ConAgra Foods Inc. (NYSE: CAG) higher Q4 earnings were in line with expectations, and shares slipped.
- Darden Restaurants Inc. (NYSE: DRI) Q4 results were higher, but it warned of continuing challenges.
- Hennes & Mauritz (OTC: HMRZF) reported strong Q2 numbers, though same-stores sales slipped.
Continue reading Earnings highlights: Nike, Oracle, Kroger, Walgreen, Monsanto, KB Home ...
Rite Aid beats analysts, but not right for me yet
Rite Aid (NYSE: RAD), which competes with Walgreen (NYSE: WAG), CVS Caremark (NYSE: CVS), and Wal-Mart (NYSE: WMT), saw a big increase in volume on Wednesday after it reported earnings for the first quarter. In fact, as Douglas McIntyre observed, shares of Rite Aid were up 5% at one point during yesterday's session. However, the shares ended up losing their green status by the close of trading. Rite Aid actually lost 3% when all was said and done. What does it all mean?
Well, Rite Aid did beat analyst forecasts by a wide margin. The call was for a loss of 13 cents per share. Rite Aid lost only 6 cents per share once adjustments are made. Revenues dipped a little over 1%, and same-store sales, after excluding the effect of the Brooks Eckerd acquisition, increased 1.5%. Interestingly, the mix of this increase is as follows: the pharmacy sales went up 3.1% on a comparable basis, and the non-pharmacy sales went down 1.4% on the same basis.
Continue reading Rite Aid beats analysts, but not right for me yet
Walgreens sells off on earnings
A down day for the market and an earnings release that left nothing to be excited about hurt shares of Walgreen Company (NYSE: WAG) today, with shares off more than 6% heading into the close. The drugstore chain, with more than 7,000 locations, reported earnings of 53 cents per share; analysts expected 56 cents on average with a low of 54 cents. Earnings in the same quarter the year before amounted to 58 cents per share.
Sales for the quarter were up 8% overall, with comparable store sales growth up 2.8%. This was largely driven by increased sales of prescription drugs in the quarter, which were up 8.2% to comprise more than 65% of revenues.
The week in preview: End-of-quarter earnings expectations: Nike, Oracle, Walgreen ...
This week brings a small flurry of end-of-the-calendar-quarter earnings reports. And for the most part, the expectations of the analysts surveyed by Thomson Reuters aren't very high. Companies expected to report declining earnings in the most recently concluded quarter include America's Car-Mart Inc. (NASDAQ: CRMT), Bed Bath & Beyond Inc. (NASDAQ: BBBY), ConAgra Foods Inc. (NYSE: CAG), Jabil Circuit Inc. (NYSE: JBL), Jackson Hewitt Tax Service Inc. (NYSE: JTX), Monsanto Co. (NYSE: MON), and Sonic Corp. (NASDAQ: SONC).











